These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9339188)

  • 1. [French screening program of breast cancer. Results from 5 districts (1989-1994)].
    Séradour B; Allemand H; Schaffer P
    Bull Cancer; 1997 Aug; 84(8):822-8. PubMed ID: 9339188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of mass screening for breast cancer in the Somme district (France) between 1990 and 1996].
    Ganry O; Peng J; Dubreuil A
    Rev Epidemiol Sante Publique; 1999 Sep; 47(4):335-41. PubMed ID: 10519174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of cancer registries in the evaluation of breast cancer screening].
    Schaffer P; Renaud R; Gairard B; Guldenfels C
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S15-21. PubMed ID: 8935860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
    Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
    Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. French colorectal cancer screening pilot programme: results of the first round.
    Goulard H; Boussac-Zarebska M; Ancelle-Park R; Bloch J
    J Med Screen; 2008; 15(3):143-8. PubMed ID: 18927097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counting the costs of mammography screening: first year results from the Sydney study.
    Gerard K; Salkeld G; Hall J
    Med J Aust; 1990 May; 152(9):466, 469-71. PubMed ID: 2381337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Breast cancer: epidemiology, risk factors, screening].
    Gairard B; Mathelin C; Schaffer P; Brettes JP
    Rev Prat; 1998 Jan; 48(1):21-7. PubMed ID: 9781206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of the Otago-Southland Breast Cancer Screening Programme 1991-1996.
    Doyle TC; Elwood JM; Smale P; Berkeley BB; Blennerhassett JB; Miller AP; Chartres SM; Hunter MH; Packer SG; Pfeifer M
    N Z Med J; 1998 Oct; 111(1075):380-3. PubMed ID: 9830418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The costs of mammography screening in New Zealand: evidence from the pilot programmes.
    Menon A; Devlin NJ; Richardson AK
    N Z Med J; 1994 Dec; 107(991):501-3. PubMed ID: 7830979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
    Taylor R; Page A; Bampton D; Estoesta J; Rickard M
    J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mass screening for breast cancer in Herault county. First results in women between 40 and 70 years old].
    Daures JP; Peray P; Bousquet J; Stoebner A; Gouzes C; Lamarque JL; Laurent JC; Cherif Cheikh J; Boulet P; Pujol J
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(2):173-8. PubMed ID: 1583294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Flemish women in semi-rural areas be motivated to attend organized breast cancer screening?
    Van Hal G; Matthyssen M; Thibaut A; Weyler J
    Rev Epidemiol Sante Publique; 1999 Apr; 47(2):119-27. PubMed ID: 10367299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Population screening for breast cancer: an interim assessment].
    van der Maas PJ
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1096-9. PubMed ID: 10876703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Simultaneous screening of cancers of the breast, cervix, colon and rectum. The Isère experience].
    Exbrayat C; Garnier A; Bolla M; Winckel P; Salicru B; Marron J; Faure H; Menegoz F; Billette de Villemeur A
    Bull Cancer; 1996 Aug; 83(8):641-8. PubMed ID: 8869044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mammographic screening of the health district 38, hospital of Gardone Val Trompia (Brescia - Lombardy). Results of the first 2 rounds].
    Nocivelli G; Bordiga G; Castellani M; Chiesa R; Donato F
    Radiol Med; 1993 Dec; 86(6):815-9. PubMed ID: 8296001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.